These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 15658019)
21. Multiple forms of exploitation in international research: the need for multiple standards of fairness. Snyder J Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969 [No Abstract] [Full Text] [Related]
22. Access to medicines and the rhetoric of responsibility. Barry C; Raworth K Ethics Int Aff; 2002; 16(2):57-70. PubMed ID: 15709279 [No Abstract] [Full Text] [Related]
23. Public health or clinical ethics: thinking beyond borders. O'Neill O Ethics Int Aff; 2002; 16(2):35-45. PubMed ID: 15709277 [No Abstract] [Full Text] [Related]
24. Declaration of ALMA-ATA. Am J Public Health; 2015 Jun; 105(6):1094-5. PubMed ID: 25970470 [No Abstract] [Full Text] [Related]
25. Protecting research and a case for optimism. Gates B Sci Transl Med; 2013 Dec; 5(214):214ed21. PubMed ID: 24307689 [No Abstract] [Full Text] [Related]
26. [International health research: priorities and commitment]. Kruse AY; Bygbjerg IC Ugeskr Laeger; 2006 Sep; 168(36):2996-8. PubMed ID: 16999885 [TBL] [Abstract][Full Text] [Related]
27. Communicable disease control: a 'Global Public Good' perspective. Smith R; Woodward D; Acharya A; Beaglehole R; Drager N Health Policy Plan; 2004 Sep; 19(5):271-8. PubMed ID: 15310662 [TBL] [Abstract][Full Text] [Related]
28. Global research partnerships in advancing public health: A case study on India. Mathew A Indian J Med Ethics; 2018; 3(4):343-344. PubMed ID: 29981234 [TBL] [Abstract][Full Text] [Related]
29. Applying a global justice lens to health systems research ethics: an initial exploration. Pratt B; Hyder AA Kennedy Inst Ethics J; 2015 Mar; 25(1):35-66. PubMed ID: 25843119 [TBL] [Abstract][Full Text] [Related]
30. Public health. Grand Challenges in Global Health. Varmus H; Klausner R; Zerhouni E; Acharya T; Daar AS; Singer PA Science; 2003 Oct; 302(5644):398-9. PubMed ID: 14563993 [TBL] [Abstract][Full Text] [Related]
31. Vaccines for children in rich and poor countries. Shann F; Steinhoff MC Lancet; 1999 Sep; 354 Suppl 2():SII7-11. PubMed ID: 10507252 [No Abstract] [Full Text] [Related]
32. Some questions about the moral responsibilities of drug companies in developing countries. Brock DW Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506 [No Abstract] [Full Text] [Related]
33. The costs of coronavirus vaccines and their pricing. Light DW; Lexchin J J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097 [No Abstract] [Full Text] [Related]
35. Funding agendas: has bioterror defense been over-prioritized? May T Am J Bioeth; 2005; 5(4):34-44. PubMed ID: 16109694 [TBL] [Abstract][Full Text] [Related]
36. Developing market. Taylor W Nat Biotechnol; 2004 Sep; 22(9):1075. PubMed ID: 15340463 [No Abstract] [Full Text] [Related]
37. Bioethics and public policy in the next millennium: presidential address. Macklin R Bioethics; 2001 Oct; 15(5-6):373-81. PubMed ID: 12058764 [No Abstract] [Full Text] [Related]
39. The Social Value of Knowledge and International Clinical Research. Wenner DM Dev World Bioeth; 2015 Aug; 15(2):76-84. PubMed ID: 26195253 [TBL] [Abstract][Full Text] [Related]
40. Profile. Dollars and cents vs. the AIDS epidemic. Vogel G Science; 2001 Jun; 292(5526):2420-2. PubMed ID: 11431547 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]